Two-dimensional echocardiographic findings in systemic sarcoidosis
References (21)
- et al.
Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II)
Am J Med
(1977) - et al.
Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids
Am J Cardiol
(1978) - et al.
Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis
Chest
(1986) - et al.
The use of 201-thallium for myocardial perfusion imaging in sarcoid heart disease
Chest
(1977) - et al.
Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients
Am J Med
(1980) - et al.
Echocardiographic evaluation of patients with systemic sarcoidosis
Am Heart J
(1985) - et al.
Cardiac sarcoidosis: a potentially treatable form of myocarditis
- et al.
Left ventricular diastolic characteristics of cardiac sarcoidosis
Am J Cardiol
(1986) - et al.
Prognostic value of predischarge 2-dimensional echocardiogram after acute myocardial infarction
Am J Cardiol
(1984) - et al.
Asymptomatic electrocardiographic alterations in sarcoidosis
Am Heart J
(1973)
Cited by (160)
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects
2024, Seminars in Nuclear MedicineMyocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review
2022, Autoimmunity ReviewsCitation Excerpt :According to several necropsy reports, about 20-28% of sarcoid patients in the United States and the United Kingdom showed histological evidence of cardiac granuloma with even a higher (50-78%) frequency among Japanese patients [5,6]. However, cardiac sarcoidosis (CS) is often unrecognized ante mortem and clinical studies discovered only a small amount of cardiac involvement (2-7%) in sarcoidosis patients [7], while occult involvement at autopsy was detected in over 20% of patients [8–11]. Table 1 lists studies reporting on cardiac involvement among sarcoidosis patients.
Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review
2022, Journal of Cardiac FailureImaging and Quantification of Cardiac Sarcoidosis
2020, Seminars in Nuclear Medicine
- 1
Dr. Burstow is supported in part by a research fellowship from the Institute for Cardiovascular Research, Brisbane, Australia, and a Travel Grant from the National Heart Foundation of Australia.